Roberto
Corchado Cobos
Investigador desde 2018
Hospital Universitario de Salamanca
Salamanca, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Salamanca (9)
2023
-
Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk
Cells, Vol. 12, Núm. 15
-
TMeB score may improve risk stratification of high-risk cutaneous squamous cell carcinoma and guide management of patients: A pilot study
Journal of the European Academy of Dermatology and Venereology
2022
-
Evolutionary Origins of Metabolic Reprogramming in Cancer
International journal of molecular sciences, Vol. 23, Núm. 20
-
Pathophysiological Integration of Metabolic Reprogramming in Breast Cancer
Cancers, Vol. 14, Núm. 2
2021
-
Definition of prognostic subgroups in the T3 stage of the eighth edition of the American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: Tentative T3 stage subclassification
Journal of the American Academy of Dermatology, Vol. 85, Núm. 5, pp. 1168-1177
-
Overcoming resistance to immunotherapy in advanced cutaneous squamous cell carcinoma
Cancers, Vol. 13, Núm. 20
-
Performance of Salamanca refinement of the T3-AJCC8 versus the Brigham and Women's Hospital and Tübingen alternative staging systems for high-risk cutaneous squamous cell carcinoma
Journal of the American Academy of Dermatology, Vol. 84, Núm. 4, pp. 938-945
2020
-
Stromal SNAI2 is required for ERBB2 breast cancer progression
Cancer Research, Vol. 80, Núm. 23, pp. 5216-5230
2019
-
MicroRNA dysregulation in cutaneous squamous cell carcinoma
International Journal of Molecular Sciences, Vol. 20, Núm. 9